Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Deficit (Unaudited)

v3.20.2
Condensed Consolidated Statement of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2018 $ 20,002 $ 12,857 $ 375,845,883 $ (415,046,606) $ (39,167,864)
Balance, shares at Dec. 31, 2018 2,000,225 128,567,273      
Conversion of Series I-2 Preferred stock into common stock $ 325,570 318,310 643,880
Conversion of Series I-2 Preferred stock into common stock, shares 3,255,700,000      
Common stock issued in cashless exercise of warrants $ 11,961 (11,961)
Common stock issued in cashless exercise of warrants, shares 119,615,384      
Modification of warrants 4,056,424 4,056,424
Stock based compensation 8,560 8,560
Deemed dividends from trigger of down round provision feature 123,861,587 (123,861,587)
Net loss (13,441,404) (13,441,404)
Balance at Mar. 31, 2019 $ 20,002 $ 350,388 504,078,893 (552,349,597) (47,900,314)
Balance, shares at Mar. 31, 2019 2,000,225 3,503,882,657      
Balance at Dec. 31, 2019 $ 20,000 $ 964,894 509,437,399 (586,942,014) (76,519,721)
Balance, shares at Dec. 31, 2019 2,000,010 9,648,936,775      
Conversion of Series I-2 Preferred stock into common stock $ 25,000 25,000
Conversion of Series I-2 Preferred stock into common stock, shares 250,000,000      
Modification of warrants        
Net loss (5,791,778) (5,791,778)
Balance at Mar. 31, 2020 $ 20,000 $ 989,894 $ 509,437,399 $ (592,733,792) $ (82,286,499)
Balance, shares at Mar. 31, 2020 2,000,010 9,898,936,775